Fluids that can be administered intravenously (IV) are called intravenous (IV) solutions. In an IV, fluid is injected through one needle and then emerges from a different needle, tube, or tube connected to tubing from which it flows into the veins of the body. It is most frequently used to deliver nutrition or medication to people who are unable to take them orally due to illness, injury, or medical conditions like cancer.

Additionally, the WHO advises treating COVID-19 patients with intravenous fluids if they have severe respiratory infections. As a result, it is anticipated that the demand for IV solutions might very well increase substantially, especially during the pandemic. In accordance with WHO statistics, there will be roughly 10 million cancer-related deaths in the world in 2020. Furthermore, over the following two decades, it is predicted that the number of cancer cases will rise by 70.0%. It is projected that rising cancer rates will help the market expand.

Intravenous Solution market
According to Marketlook Consulting’s research report “Global Intravenous Solution Market Analysis, 2021”, the Global Intravenous Solution market is anticipated to grow at a CAGR of 8% during 2022-29. The market would reach USD 20.5 Bn by 2029.

Based on Product Type, the IV solution is segmented into Partial Parenteral Nutrition and Total Parenteral Nutrition. In 2021, the total parenteral nutrition (TPN) segment had the highest revenue share and is also expected to have the highest CAGR during the forecast year.

Based on Nutrients Type, the market is divided into Carbohydrates, Salts and Electrolytes, Minerals, Vitamins, and Amino Acids. The single-dose amino acid solutions segment grabbed the major market share and dominated the market in 2021.

“Global Intravenous Solution Market Analysis, 2021” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for Intravenous Solution providers across the Globe. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitors’ capabilities on 16 parameters. This will help companies in the formulation of Go to Market Strategies and identifying the blue ocean for its offerings.

Request For Sample:- https://marketlookconsulting.com/sample-request/263

North America Dominated the Market

Based on Leading regions, North America dominated the global Intravenous Solution market in 2021 and is projected to maintain its dominance during the forecasted period 2022-29 due to an increase in the number of elderly people, which raises the demand for intravenous solutions, the prevalence of chronic diseases, and the industry's expansion to meet the growing demand brought on by the flu and coronavirus pandemic. Also, cancer is the second most common cause of death in Americans, according to the Centers for Disease Control and Prevention. In the United States, cancer is responsible for about one in four fatalities. According to a report by the American Cancer Society, there will be roughly 1,806,590 new cases of cancer and 606,520 deaths in the United States in 2020.

Intravenous Solution in the forthcoming period as stated in Marketlook Consulting research report “Global Intravenous Solution Market Analysis, 2021”.

According to Marketlook Consulting’, the key players with a considerable market share in the global Intravenous Solution market are Amanta Healthcare Ltd., Axa Parenterals Ltd., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Eurolife Healthcare Pvt Ltd., Fresenius Kabi AG, Grifols S.A., Henry Schein Inc, ICU Medical, Inc.

Read More:- https://marketlookconsulting.com/reports/intravenous-solutions-market

Market Segmentation:
1. By Type (Partial Parenteral Nutrition, Total Parenteral Nutrition.)
2. By Nutrients Type (Carbohydrates, Salts and Electrolytes, Minerals, Vitamins, Amino Acids)
3. By Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa)
4. By Company (Amanta Healthcare Ltd., Axa Parenterals Ltd., B. Braun Melsungen AG, Baxter International Inc.,
Becton, Dickinson and Company, Eurolife Healthcare Pvt Ltd., Fresenius Kabi AG, Grifols S.A., Henry Schein
Inc, ICU Medical, Inc.)

Key questions answered in the study:
1. What are the current and future trends of the Intravenous Solution industry?
2. How the industry has been evolving in terms of type and nutrition type?
3. How the competition has been shaping across the countries followed by their comparative factorial
indexing?
4. What are the key growth drivers and challenges for the Intravenous Solution industry?
5. What is the customer orientation, purchase behavior, and expectations from the Intravenous Solution firms
across various regions?

About Us:-
Marketlook Consulting is a world market intelligence and consulting firm that aims to offer business insights and market research reports to large as well as small & medium scale enterprises (SMEs). The company helps its clients to design business strategies and policies and accomplish sustainable growth in their relevant market area.

Contact US:-
Phone:- +91 9660950683
Name:- Mithun Jangir (Manager- Marketing & Communications)
Email:- [email protected]
LinkedIn:- https://www.linkedin.com/company/marketlook-consulting
U 26C/6, DLF Phase 3, Gurgaon 122002